Active Ingredient(s):Etravirine FDA Approved: * January 18, 2008 Pharm Company: *TIBOTEC Category:HIV / AIDS
Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Janssen, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for pati...
* May have multiple approval dates, manufacturers, or labelers.